US-made antiviral drug could become standard in COVID-19 treatment
Dr. Anthony Fauci, chief expert on infectious diseases in the White House working group, said Gilead Sciences' experimental antiviral drug will become the standard in the treatment of COVID-19, reports Voice of America.
Photo: Shutterstock
According to a key clinical study, doctors concluded that remdesivir manufactured by Gilead Sciences helps in recovering patients with COVID-19, a coronavirus disease, and also reduces mortality.
Preliminary results from a study conducted by the US authorities show that patients who were given remdesivir recovered 31% faster than patients who were given placebo - dummy tablets as part of the study. Anthony Fauci called these results "extremely significant."
“This is really very important,” said Fauchi, speaking to reporters in the White House. He compared this event with 1986, when doctors first discovered a drug that can treat HIV infection.
“This will be the standard of care,” said Dr. Fauci.
The Food and Drug Administration (FDA) is in talks with the drug manufacturer, Gilead, to provide it as soon as possible for the needs of patients.
“I want them to do this as soon as possible,” said President Donald Trump, answering the question of whether the FDA can urgently issue permission to use remdesivir in the treatment of COVID-19. The President noted that the administration is most concerned about the safety of the drug, however, “I would like to get approval very quickly, especially when it comes to a drug that works.”
However, Anthony Fauci warned that the latest clinical research data still needs to be carefully analyzed.
Doctors around the world showed an extremely high interest in remdesivir (an experimental antiviral drug that was originally intended to treat Ebola) due to the lack of a standard of therapy and a vaccine against COVID-19, which affects the lungs and other organs in especially severe cases.
In April, Gilead representatives said the company was ready to donate 1,5 million doses of remdesivir to hospitals, which is enough for more than 140 thousand patients, depending on the length of treatment. Approval of the drug by the FDA will allow it to begin commercial sales.
On the subject: Each of us can help find a cure for COVID-19: for this you need to play a game
The National Institute of Allergy and Infectious Diseases, part of the National Institute of Health (NIH), reported preliminary results from a clinical study in which 1063 patients with COVID-19 participated. Patients receiving remdesivir recovered on average 11 days later, unlike those given a placebo: on average, they recovered after 15 days.
The study also showed that remdesivir may improve patient survival rates. Among patients receiving the drug, 19% died from COVID-8,0. Moreover, in the placebo group, 11,6% of patients became the victims of the disease. However, the difference is not statistically significant, and the increase in survival may not be related to the drug.
The full results of the study will be published in mid-May at the National Institute of Health.
As ForumDaily wrote earlier:
- Coronavirus hardly spreads across surfaces: important new research data
- Research: coronavirus mutated in tens different strains
- In the United States to fight against coronavirus robots
- Study: owners pets easier to carry COVID-19
Read also on ForumDaily:
The US economy showed the largest decline in 10 years due to coronavirus: what's next
The vaccine from COVID-19 has already been created and tested: when will it be publicly available
20 professions with the highest risk of coronavirus infection
Subscribe to ForumDaily on Google NewsDo you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.
-
Personal experience: who and why you should not move to the USA5614
-
50 diseases whose presence will increase the cost of health insurance in the USA4329
-
Great opportunities with ChatGPT: 12 easy ways to make money using artificial intelligence1324
-
What should not be on your resume if you want to find a job in the USA763
-
Four unforgivable mistakes immigrants make to the United States552
-
Dependence on cars and one supermarket per city: why ours is unusual in one-story America403
-
Ten secret restaurants in the USA: what is their highlight and how to find them254
-
Personal experience: who and why you should not move to the USA5614
-
Where in the USA to buy the medicines we are used to: a list of pharmacies5330
-
How to hit the jackpot: tips from a man who won the lottery 7 times4898
-
50 diseases whose presence will increase the cost of health insurance in the USA4329
-
Street, avenue, boulevard or drive: how to understand the classification of US streets and roads1461
-
Personal experience: what not to do in America1402
-
Great opportunities with ChatGPT: 12 easy ways to make money using artificial intelligence1324